Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 4,783
Out of 4,944 analysts
6
Total ratings
n/a
Success rate
-36.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $1.35 | +48.15% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $40.38 | +135.26% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $91.79 | +36.18% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $5.45 | +83.49% | 1 | Mar 21, 2023 | |
| AXGN Axogen | Assumes: Buy | $15 | $14.76 | +1.63% | 1 | Nov 11, 2022 |
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $1.35
Upside: +48.15%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $40.38
Upside: +135.26%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $91.79
Upside: +36.18%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $5.45
Upside: +83.49%
Axogen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $14.76
Upside: +1.63%